Physician profile
Eric M Thompson
NPI 1942208202
$553.42
in general payments reported to CMS, 2019-2025
11 companies · $79.01 in 2025
The $79.01 reported for 2025 was less than what a typical Foot Surgery provider received nationally (typical 2025 total: $180).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $147 · 2020: $22.14 · 2021: $125 · 2022: $22.38 · 2023: $82.58 · 2024: $76.20 · 2025: $79.01.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $238.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $237.79 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Smith+Nephew, INC. | $120.57 | 2020-2024 | Collagenase Santyl |
| Misonix INC | $102.67 | 2021 | |
| Stryker Corporation | $85.12 | 2019-2024 | Allowrap |
| Glaxosmithkline, LLC. | $56.90 | 2023 | Nucala |
| Kerecis Limited | $48.70 | 2019 | |
| Mimedx Group, INC. | $36.38 | 2025 | |
| Hydrofera LLC | $24.30 | 2025 | Hydrofera Blue |
| E.R. Squibb & Sons, L.L.C. | $21.65 | 2019 | |
| Kci USA, INC. | $20.55 | 2019 | |
| Bone Support INC. | $18.33 | 2025 | Ceramentbone Void Filler, Cerament G |
| Organogenesis INC. | $18.25 | 2024 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Eric Thompson listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.